Because MDA-MB-231 cells, which are of mesenchymal origin and have a triple-negative phenotype[22], are well known to be resistant to several DNA-damaging agents, these data suggested that DSS1 depletion can increase chemosensitivity in drug-resistant breast cancer cells with either wild type or mutant p53. This evidence concerns the gene TP53 and breast carcinoma.